|
|
Article: PSA velocity useful in predicting prostate cancer.(Urology)(prostate-specific antigen)
- Article from:
- Internal Medicine News
- Article date:
- August 1, 2006
- Author:
CopyrightCOPYRIGHT 2006 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ATLANTA -- A prostate-specific antigen velocity threshold of approximately 0.4 ng/mL a year is a useful predictor of prostate cancer risk in men under the age of 60 years who have lower median PSA levels, according to research presented at the annual meeting of the American Urological Association.
"A decade ago, it was thought that a PSA velocity threshold of 0.75 ng/mL per year was useful to distinguish between prostate cancer and benign conditions and that total PSA levels between 4 and 10 warranted a biopsy. However, in the modern era, many men present with lower total PSA levels, particularly younger men," said the lead author, Dr. Stacy Loeb of Georgetown ...